ADA Scientific Sessions 2026 Abstract

Zenagamtide Targets Key Feeding-Related Brain Regions and Induces Weight Loss by Preferentially Reducing Consumption of Unhealthy Solid and Liquid Diets in Rats

By David Ipsen, Andreas Vegge, Anna Secher, Kirsten Raun, Sofia Hult Lundh

Experiments in animalsInterventions

The paper

David Ipsen, Andreas Vegge, Anna Secher, Kirsten Raun, Sofia Hult Lundh

Måløv

ADA Scientific Sessions 2026 Abstract, 8 Jun 2026

Presented at ADA Scientific Sessions 2026, oral 1323-OR

doi.org/10.2337/db26-1323-or

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs